KADIAN Drug Patent Profile

✉ Email this page to a colleague

When do Kadian patents expire, and when can generic versions of Kadian launch?

Kadian is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in KADIAN is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Kadian

A generic version of KADIAN was approved as morphine sulfate by HOSPIRA on May 11^th, 1988.

Try a Trial

Summary for KADIAN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	24
Clinical Trials:	16
Patent Applications:	5,830
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for KADIAN
What excipients (inactive ingredients) are in KADIAN?	KADIAN excipients list
DailyMed Link:	KADIAN at DailyMed

Drug patent expirations by year for KADIAN

Recent Clinical Trials for KADIAN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of British Columbia	Phase 4
The Ottawa Hospital	Phase 3
Bruyere Research Institute	Phase 3

See all KADIAN clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for KADIAN

N02AA	Natural opium alkaloids
N02A	OPIOIDS
N02	ANALGESICS
N	Nervous system

US Patents and Regulatory Information for KADIAN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-008	Apr 20, 2007		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-010	Jul 9, 2012		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-009	Jul 9, 2012		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-007	Feb 27, 2007		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-006	Oct 27, 2006		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-001	Jul 3, 1996		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for KADIAN

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-005	Mar 9, 2001	⤷ Try a Trial	⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-002	Jul 3, 1996	⤷ Try a Trial	⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-001	Jul 3, 1996	⤷ Try a Trial	⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-007	Feb 27, 2007	⤷ Try a Trial	⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-001	Jul 3, 1996	⤷ Try a Trial	⤷ Try a Trial
Allergan	KADIAN	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	020616-008	Apr 20, 2007	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for KADIAN

See the table below for patents covering KADIAN around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Japan	2937376		⤷ Try a Trial
Spain	2085886		⤷ Try a Trial
European Patent Office	0377518	Composition pharmaceutique à libération retardée (Sustained release pharmaceutical composition)	⤷ Try a Trial
Canada	2007181	COMPOSE PHARMACEUTIQUE A LIBERATION CONTINUE (SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION)	⤷ Try a Trial
Australia	617573		⤷ Try a Trial
Denmark	0609961		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for KADIAN

Recent Clinical Trials for KADIAN

Anatomical Therapeutic Chemical (ATC) Classes for KADIAN

Make Better Decisions: Try a trial or see plans & pricing